Internal Medicine

Internal Medicine
Open Access

ISSN: 2165-8048

Xiao-Jian Yao

Xiao-Jian Yao

Xiao-Jian Yao
Associate Professor, Department of Medical Microbiology
University of Manitoba, Canada

Biography

Dr. Yao obtained his M.D. and M.Sc. degrees respectively at Suzhou Medical University and National Institute for the Control of Pharma. and Biol. Products in China. Then, he went to Canada and got his Ph.D. degree in 1996 in Dr. E. Cohen’s lab at University of Montreal. Dr. Yao was one of several scientists who first characterized the anti-HIV compound 3TC in vitro.
Since 2004, he established his Human Molecule Laboratory in the University of Manitoba. Now, he is Associate Professor and the Director, Laboratory of Molecular Human Retrovirology, Department of Medical Microbiology, University of Manitoba. His lab mainly focuses on HIV and host protein interactions and their functional roles during HIV-1 replication. The optimal goal of his research is to gain better understanding of the mechanism underlying HIV replication and to translate research findings into knowledge for better designing of specific strategies to block HIV infection.

Research Interest

Dr. Yao obtained his M.D. and M.Sc. degrees respectively at Suzhou Medical University and National Institute for the Control of Pharma. and Biol. Products in China. Then, he went to Canada and got his Ph.D. degree in 1996 in Dr. E. Cohen’s lab at University of Montreal. Dr. Yao was one of several scientists who first characterized the anti-HIV compound 3TC in vitro.
Since 2004, he established his Human Molecule Laboratory in the University of Manitoba. Now, he is Associate Professor and the Director, Laboratory of Molecular Human Retrovirology, Department of Medical Microbiology, University of Manitoba. His lab mainly focuses on HIV and host protein interactions and their functional roles during HIV-1 replication. The optimal goal of his research is to gain better understanding of the mechanism underlying HIV replication and to translate research findings into knowledge for better designing of specific strategies to block HIV infection.

Top